MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
51.77
+1.95 (3.91%)
Nov 21, 2024, 1:59 PM EST - Market open
MLTX Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,262 | 3,620 | 409 | - |
| Market Cap Growth | 4.00% | 784.47% | - | - |
| Enterprise Value | 2,659 | 3,189 | 353 | - |
| Last Close Price | 49.82 | 60.39 | 10.50 | 9.89 |
| PB Ratio | 6.43 | 7.05 | 5.95 | - |
| P/TBV Ratio | 6.50 | 7.30 | 8.37 | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | -1.29 |
| Quick Ratio | 24.72 | 51.38 | 9.44 | 0.39 |
| Current Ratio | 25.51 | 51.59 | 9.98 | 0.46 |
| Return on Equity (ROE) | -16.80% | -15.14% | -225.85% | - |
| Return on Assets (ROA) | -13.32% | -11.21% | -93.99% | - |
| Return on Capital (ROIC) | -13.72% | -11.54% | -112.32% | - |
| Earnings Yield | -2.58% | -0.99% | -12.21% | - |
| FCF Yield | -2.59% | -1.19% | -13.66% | - |
| Buyback Yield / Dilution | -40.83% | -67.30% | -274.47% | - |
| Total Shareholder Return | -40.83% | -67.30% | -274.47% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.